This company listing is no longer active
LogicBio Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Key information
37.7%
Debt to equity ratio
US$5.93m
Debt
| Interest coverage ratio | n/a |
| Cash | US$30.78m |
| Equity | US$15.74m |
| Total liabilities | US$22.86m |
| Total assets | US$38.60m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0IF's short term assets ($32.8M) exceed its short term liabilities ($16.4M).
Long Term Liabilities: 0IF's short term assets ($32.8M) exceed its long term liabilities ($6.4M).
Debt to Equity History and Analysis
Debt Level: 0IF has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 0IF's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 0IF has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 0IF has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 15.8% each year.